Medicinal strategies in the treatment of obesity
- 1 April 2000
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 404 (6778) , 672-677
- https://doi.org/10.1038/35007544
Abstract
When prevention fails, medicinal treatment of obesity may become a necessity. Any strategic medicinal development must recognize that obesity is a chronic, stigmatized and costly disease that is increasing in prevalence. Because obesity can rarely be cured, treatment strategies are effective only as long as they are used, and combined therapy may be more effective than monotherapy. For a drug to have significant impact on body weight it must ultimately reduce energy intake, increase energy expenditure, or both. Currently approved drugs for long-term treatment of obesity include sibutramine, which inhibits food intake, and orlistat, which blocks fat digestion.Keywords
This publication has 77 references indexed in Scilit:
- Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin DeficiencyNew England Journal of Medicine, 1999
- Original Articles Sibutramine Reduces Food Intake in Non‐Dieting Women with ObesityObesity Research, 1998
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Enterostatin‐A Peptide Regulating Fat IntakeObesity Research, 1997
- Effects of pyruvate and lactate on food intake in rat strains sensitive and resistant to dietary obesityPhysiology & Behavior, 1996
- Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db MiceCell, 1996
- Abnormal splicing of the leptin receptor in diabetic miceNature, 1996
- Dopamine Receptor Subtype Agonists and Feeding BehaviorObesity Research, 1995
- Topical Fat ReductionObesity Research, 1995
- Androgen Treatment of Abdominally Obese MenObesity Research, 1993